[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"colonoscopy\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:colonoscopy":29},{"pageToken":4,"total":5,"offset":6,"count":7,"results":8},null,45,0,25,[9,43,67,86,115,146,170,194,218,241,259,285,305,320,347,376,397,428,448,476,495,522,546,572,594],{"id":10,"slug":11,"hasResults":12,"nctId":13,"briefTitle":14,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":42},"100053729","administration-of-a-thirst-relieve-kit-versus-placebo-in-patients-after-hospital-based-bowel-preparation-for-colonoscopy-and-assessment-of-thirst-intensity-100053729",false,"NCT07699809","Administration of a 'Thirst Relieve Kit' Versus Placebo in Patients After Hospital-based Bowel Preparation for Colonoscopy and Assessment of Thirst Intensity","Inclusion Criteria:\n\n* both sexes\n* aged 18 years or older, with clear awareness and good cooperation\n* who underwent colonoscopy with hospital bowel preparation\n\nExclusion Criteria:\n\n* any risk of oral fluid aspiration\n* swallowing disorders\n* post-operative advanced head and neck surgeries\n* advanced head and neck neoplasia, active oral diseases (oral mucosal lesions, stomatitis, among others)\n* history of gastric surgeries (gastrectomized, upper gastrointestinal tract surgeries for obesity)\n* use of GLP-1 analog medications and derivatives in the last 10 days according to hospital protocol (e.g., semaglutide, liraglutide, dulaglutide, tirzepatide...)\n* history of dementia.",true,"ALL","18 Years",{"count":20,"type":21},158,"ESTIMATED","INTERVENTIONAL",[24],"NA","The goal of this study is to evaluate whether a \"thirst kit\" (lemon popsicle) is effective in reducing thirst intensity in patients undergoing hospital bowel preparation for colonoscopy. The study also aims to assess the impact of the thirst kit on associated symptoms and patient satisfaction. The main questions it aims to answer are:\n\n* Does the thirst kit reduce the intensity of thirst after bowel preparation for colonoscopy?\n* Does the thirst kit reduce symptoms such as dry mouth and dry throat?\n* How satisfied are patients when using the thirst kit compared to a placebo?\n\nResearchers will compare the thirst kit to a placebo to determine its effectiveness in managing thirst during the pre-colonoscopy period.\n\nParticipants will:\n\n* Be randomly assigned to receive either the thirst kit (lemon popsicle) or a placebo\n* Use the assigned intervention during the hospital preparation period for colonoscopy\n* Rate thirst intensity, associated symptoms, and satisfaction using numerical scales",[27,28,29],"Thirst","Bowel Preparation for Colonoscopy","Colonoscopy","RECRUITING","2026-07-07",{"date":33,"type":34},"2026-07-13","ACTUAL",{"date":36,"type":34},"2025-12-08",{"date":38,"type":21},"2026-09-01",{"name":40,"class":41},"Hospital Sirio-Libanes","OTHER",1,{"id":44,"slug":45,"hasResults":12,"nctId":46,"briefTitle":47,"officialTitle":47,"acronym":4,"eligibilityCriteria":48,"healthyVolunteers":12,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":49,"targetDuration":4,"studyType":51,"phases":4,"briefSummary":52,"conditions":53,"keywords":4,"overallStatus":57,"whyStopped":4,"lastUpdateSubmitDate":58,"lastUpdatePostDateStruct":59,"startDateStruct":61,"completionDateStruct":63,"leadSponsor":65,"locationsCount":4},"100644015","the-effect-of-ph-value-of-water-consumed-during-bowel-preparation-before-colonoscopy-on-colon-cleansing-100644015","NCT07669116","The Effect of pH Value of Water Consumed During Bowel Preparation Before Colonoscopy on Colon Cleansing.","Inclusion Criteria::\n\n* Age over 18\n* Fully adhering to the pre-procedure diet\n* Bowel preparation performed with the bowel preparation routinely used in our surgical endoscopy unit (Sennoside A+B, Monobasic sodium phosphate+ Dibasic sodium phosphate)\n* No history of gastrointestinal surgery\n* Patients not using prokinetic drugs\n\nExclusion Criteria:\n\n* Those not following the diet\n* Those using another bowel preparation\n* Those with a history of stomach, small intestine, large intestine surgery or any major abdominal surgery for any reason\n* Those diagnosed with a known bowel disease such as inflammatory bowel disease or irritable bowel syndrome\n* Those with gastrointestinal motility disorders or those using medications that may cause this side effect\n* Patients for whom the pH value\u002Fcontent of drinking water cannot be obtained",{"count":50,"type":21},1200,"OBSERVATIONAL","Colonoscopy is a commonly used minimally invasive method for evaluating the lower gastrointestinal tract. The quality of colonoscopy is assessed by factors such as cecal intubation rate and adenoma detection rate, both of which are affected by bowel preparation. Adequate bowel cleansing is critical for an ideal colonoscopy. Inadequate bowel preparation can prolong the procedure time, miss pathological findings, and increase hospital costs due to repeated procedures. Studies have shown that nearly 25% of patients have inadequate bowel preparation. Several factors influence bowel cleansing, including diet, bowel preparation medication, and a history of gastrointestinal surgery. In a study by Liu Shi et al., male gender, hospitalization, and spring season were reported as independent risk factors for inadequate bowel preparation. A retrospective US study associated age ≥66 with poor colonoscopy preparation, while two Asian studies associated age ≥60. Comorbidities such as diabetes, stroke, and dementia, as well as low socioeconomic status, have also been reported to negatively impact adequate bowel cleansing.\n\nThe Aronchick scale, Ottawa Bowel Preparation Scale (OBPS), and Boston Bowel Preparation Scale (BBPS) are commonly used in bowel preparation scoring. The BBPS is rated from 0 to 9, with 9 considered excellent bowel preparation. It is applied after cleansing and aspiration of colon segments, which are divided into right, transverse, and left colon. Among the current scoring systems, the BBPS is the most useful and reliable scale.\n\nThe positive effects of alkaline pH water on the gastrointestinal system are well known. Alkaline mineral water has positive effects on intestinal epithelial regeneration, inflammatory response, improved barrier function, and antioxidant mechanisms.\n\nIn our study, we aimed to investigate the effect of the pH value of water consumed during bowel preparation before colonoscopy on bowel cleansing.\n\nDemographic, clinical, and intraoperative data of patients undergoing colonoscopy in our hospital's surgical endoscopy unit between July 2026 - July 2027 will be examined. Patients meeting the inclusion criteria will be included in the study. For pre-procedure information, all patients will be given a bowel preparation form by the surgical endoscopy unit, and patients who do not fully adhere to the diet will be excluded from the study. Informed consent will be obtained from the patients or their legal representatives. All procedures will be performed under sedation with the assistance of an anesthesiologist. Bowel cleansing will be assessed according to the Boston Bowel Preparation Scale (BBHS). The pH value and content of the drinking water will be noted when the bowel preparation form is given; no specific instructions will be given regarding this. However, patients will be asked to use the same water throughout the bowel preparation period. Data regarding drinking water will be confirmed on the day of the procedure for a second check.\n\nOur study will be the first of its kind in this field.",[29,54,55,56],"Bowel Cleansing","Water Intake","pH","NOT_YET_RECRUITING","2026-06-21",{"date":60,"type":34},"2026-06-25",{"date":62,"type":21},"2026-07-25",{"date":64,"type":21},"2027-06-25",{"name":66,"class":41},"Sinan Ömeroğlu, MD",{"id":68,"slug":69,"hasResults":12,"nctId":70,"briefTitle":71,"officialTitle":71,"acronym":4,"eligibilityCriteria":72,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":73,"targetDuration":4,"studyType":51,"phases":4,"briefSummary":75,"conditions":76,"keywords":4,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":77,"lastUpdatePostDateStruct":78,"startDateStruct":80,"completionDateStruct":82,"leadSponsor":84,"locationsCount":42},"100641967","evaluating-the-effectiveness-of-a-colonoscopy-surveillance-recommendations-algorithm-in-clinical-practice-100641967","NCT07658716","Evaluating the Effectiveness of a Colonoscopy Surveillance Recommendations Algorithm in Clinical Practice","Inclusion Criteria:\n\n* Gastroenterologists and primary care physicians, including residents and fellows, currently practicing at NYU Langone Health, and Bellevue.\n* Willing and able to provide consent\n\nExclusion Criteria:\n\n* Physicians not practicing in relevant fields or those with conflicts of interest.",{"count":74,"type":21},100,"The primary objective is to determine if the use of the colonoscopy surveillance recommendations algorithm increases the accuracy of surveillance timing recommendations compared to traditional methods. The secondary objective is to assess the time required to make surveillance recommendations with and without the algorithm, determine the efficiency gains (the average time saved per recommendation), and evaluate the opportunity cost (the financial value of the time saved).",[29],"2026-06-16",{"date":79,"type":34},"2026-06-22",{"date":81,"type":34},"2026-03-24",{"date":83,"type":21},"2028-03-24",{"name":85,"class":41},"NYU Langone Health",{"id":87,"slug":88,"hasResults":12,"nctId":89,"briefTitle":90,"officialTitle":91,"acronym":4,"eligibilityCriteria":92,"healthyVolunteers":12,"sex":17,"minAge":18,"maxAge":93,"enrollmentInfo":94,"targetDuration":4,"studyType":22,"phases":96,"briefSummary":97,"conditions":98,"keywords":102,"overallStatus":57,"whyStopped":4,"lastUpdateSubmitDate":106,"lastUpdatePostDateStruct":107,"startDateStruct":108,"completionDateStruct":110,"leadSponsor":112,"locationsCount":4},"100643045","opioid-free-versus-opioid-based-sedation-for-endoscopic-procedures-100643045","NCT07649746","Opioid-Free Versus Opioid-Based Sedation for Endoscopic Procedures","Evaluation of an Opioid-Free Approach in Sedation Method Selection in Endoscopy Units: A Prospective Randomized Observational Double-Blind Comparison of Dexmedetomidine (Opioid-Free) and Remifentanil-Dexmedetomidine (Opioid-Based) Combination","Inclusion Criteria:\n\n* Age 18 to 85 years\n* ASA physical status I-III\n* Scheduled for ERCP, gastroscopy, or colonoscopy\n\nExclusion Criteria:\n\n* Refusal to participate in the study\n* Inability to communicate\n* Alcohol or substance abuse\n* Neuropsychiatric disease\n* Severe respiratory failure\n* Severe heart failure\n* Pregnancy\n* Body mass index (BMI) \\>30 kg\u002Fm²\n* Hearing impairment\n* History of allergy to study medications\n* Requirement for orotracheal intubation or general anesthesia\n* Procedures lasting less than 20 minutes","85 Years",{"count":95,"type":21},80,[24],"This study will compare two different sedation approaches used during gastroscopy, colonoscopy, and endoscopic retrograde cholangiopancreatography (ERCP). One group will receive dexmedetomidine alone (opioid-free sedation), while the other group will receive dexmedetomidine combined with remifentanil (opioid-based sedation).\n\nThe purpose of the study is to determine whether an opioid-free sedation approach can reduce opioid-related adverse symptoms, such as nausea, vomiting, dizziness, drowsiness, dry mouth, headache, and fatigue. The study will also evaluate quality of recovery, patient and healthcare staff satisfaction, hemodynamic effects, complications, and time to discharge after the procedure.",[99,100,29,101],"Sedation","Endoscopy","Endoscopic Retrograde Cholangiopancreatography (ERCP)",[103,104,105,99,100],"Dexmedetomidine","Opioid-Free Sedation","Remifentanil","2026-06-10",{"date":77,"type":34},{"date":109,"type":21},"2026-06",{"date":111,"type":21},"2028-02",{"name":113,"class":114},"Bakirkoy Dr. Sadi Konuk Research and Training Hospital","OTHER_GOV",{"id":116,"slug":117,"hasResults":12,"nctId":118,"briefTitle":119,"officialTitle":120,"acronym":4,"eligibilityCriteria":121,"healthyVolunteers":16,"sex":17,"minAge":122,"maxAge":123,"enrollmentInfo":124,"targetDuration":4,"studyType":22,"phases":126,"briefSummary":127,"conditions":128,"keywords":130,"overallStatus":57,"whyStopped":4,"lastUpdateSubmitDate":137,"lastUpdatePostDateStruct":138,"startDateStruct":140,"completionDateStruct":142,"leadSponsor":144,"locationsCount":4},"100638461","ai-empowered-nudge-to-improve-colonoscopy-uptake-ainc-100638461","NCT07612436","AI-empowered Nudge to Improve Colonoscopy Uptake (AINC)","AI-empowered Nudge to Improve Colonoscopy Uptake (AINC): A Pragmatic Cluster-Randomized Trial","Inclusion Criteria:\n\n* Aged 45-74 years;\n* Test positive on the Colorectal Cancer Risk Assessment Scale and the immunochemical fecal occult blood test;\n* In good general health, mentally competent;\n* Provide informed consent.\n\nExclusion Criteria:\n\n* History of colorectal resection;\n* Previous diagnosis of cancer or currently undergoing any cancer-related treatment;\n* Underwent a colonoscopy or sigmoidoscopy within the past 5 years;\n* Contraindications to colonoscopy (e.g. severe cardiac, cerebral, lung diseases, or renal dysfunction).","45 Years","74 Years",{"count":125,"type":21},1680,[24],"Colorectal cancer (CRC) ranks third in both incidence and mortality among all malignant tumors in China. Studies have shown that early screening can significantly reduce its incidence and mortality. Colonoscopy is the gold standard for CRC screening; however, compliance with colonoscopy among high-risk groups in China is very low. Artificial intelligence (AI)-assisted tools can provide real-time, personalized health education, and nudge strategies can help translate intent into action. This trial aims to evaluate the effectiveness of AI-empowered nudge for improving colonoscopy uptake among high-risk individuals aged 45 to 74 in China. It's a two-arm, pragmatic cluster randomized controlled trial. The main question it aims to answer is whether the AI-enabled personalized health education and nudge strategies improve colonoscopy adherence.\n\nParticipants will:\n\n1. Be recruited and allocated into one of two groups according to the assigned clusters. Participants in one group will be invited to receive usual care. In addition to usual care, participants in the other group will receive AI-empowered nudge, featuring an AI chatbot providing real-time personalized responses and a nudge environment with default screening option.\n2. Have their colonoscopy status checked at the end of trial.",[129,29],"Colorectal Neoplasms",[131,132,133,134,135,136],"Colorectal cancer","artificial intelligence","screening adherence","randomized controlled trial","nudge","Behavioral intervention","2026-06-03",{"date":139,"type":34},"2026-06-04",{"date":141,"type":21},"2026-05-30",{"date":143,"type":21},"2027-12-31",{"name":145,"class":41},"Fudan University",{"id":147,"slug":148,"hasResults":12,"nctId":149,"briefTitle":150,"officialTitle":150,"acronym":4,"eligibilityCriteria":151,"healthyVolunteers":12,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":152,"targetDuration":4,"studyType":22,"phases":154,"briefSummary":155,"conditions":156,"keywords":158,"overallStatus":57,"whyStopped":4,"lastUpdateSubmitDate":161,"lastUpdatePostDateStruct":162,"startDateStruct":164,"completionDateStruct":166,"leadSponsor":168,"locationsCount":4},"100639002","comparison-of-the-diagnostic-accuracy-between-three-dimensional-and-standard-colonoscopy-of-colorectal-polyps-100639002","NCT07619248","Comparison of the Diagnostic Accuracy Between Three Dimensional and Standard Colonoscopy of Colorectal Polyps","Inclusion Criteria:\n\n* Patients aged 18 years or older.\n* Patients who meet the indications for undergoing colonoscopy.\n\nExclusion Criteria:\n\n* Patients younger than 18 years of age or those with contraindications precluding them from undergoing a colonoscopy.\n\n(Contraindications for colonoscopy: patients with a recent history of myocardial infarction, pulmonary embolism, cerebrovascular infarction, severe unstable cardiovascular disease, acute abdominal inflammation combined with peritonitis, fulminant colitis, acute diverticulitis, colonic perforation, or toxic megacolon).\n\n* Patients with familial hereditary colorectal cancer or colonic polyposis syndromes.\n* Patients with inflammatory bowel disease (IBD).\n* Subjects who are unable to complete the colonoscopy or those with poor bowel preparation.\n* Subjects who are unable to confirm the date of their previous colonoscopy.",{"count":153,"type":21},600,[24],"Colorectal cancer (CRC) is one of the most common cancers worldwide. These malignancies originate in the colon or rectum, and the majority evolve from pre-existing colonic adenomas (a type of colon polyp). Early detection, identification, and removal of these precancerous lesions can effectively reduce the morbidity and mortality of colorectal cancer.\n\nHowever, not all colonic polyps possess a significant risk of malignant transformation. Polyps can generally be subdivided into \"neoplastic\" and \"non-neoplastic\" lesions; major non-neoplastic polyps include inflammatory polyps, hamartomas, lymphoid polyps, mucosal prolapse polyps, and hyperplastic polyps. On the other hand, neoplastic polyps have the potential to develop into malignancies, primarily including adenomatous polyps and serrated polyps. Adenomatous polyps account for more than 50% of all colonic polyps and are the most common precancerous lesions for CRC. Clinically, they can be further classified into tubular, tubulovillous, or villous adenomas based on histological subtypes. As for serrated polyps, traditional serrated adenomas (TSAs) and sessile serrated lesions (SSLs) possess carcinogenic potential.\n\nDuring a colonoscopy, detecting colonic polyps is crucial, but it is equally important to identify which polyps have malignant potential. This allows for the accurate resection of true precancerous lesions while avoiding the procedural risks associated with unnecessary polypectomies. Furthermore, in rare instances, diminutive polyps may harbor cancer with deep submucosal invasion. Due to the risks of incomplete resection and lymph node metastasis, such lesions are not suitable for endoscopic resection. Therefore, achieving an accurate endoscopic diagnosis is a key step in determining the most appropriate management strategy for colonic polyps.\n\nTo improve the diagnostic accuracy of endoscopy for colonic polyps, multiple modalities have been developed, including careful observation of lesion morphology, as well as various image-enhanced technologies and chromoendoscopy. Meanwhile, three-dimensional (3D) endoscopy, a novel technology, offers superior spatial resolution and depth perception compared to conventional two-dimensional (2D) endoscopy. Studies have confirmed that 3D endoscopy can improve the adenoma detection rate (ADR) due to its enhanced ability to detect flat and inconspicuous lesions. However, whether 3D colonoscopy can also enhance the endoscopic diagnostic accuracy for colonic polyps remains to be explored. Therefore, we designed a randomized controlled trial (RCT) to investigate whether 3D colonoscopy can improve the diagnostic accuracy of colonic polyps compared to conventional 2D colonoscopy.",[157,29],"Colo-rectal Polyps",[100,29,159,160],"Colo-rectal polyps","3D Endoscopy","2026-05-28",{"date":163,"type":34},"2026-06-01",{"date":165,"type":21},"2026-05-12",{"date":167,"type":21},"2027-05-12",{"name":169,"class":41},"National Taiwan University Hospital",{"id":171,"slug":172,"hasResults":12,"nctId":173,"briefTitle":174,"officialTitle":175,"acronym":4,"eligibilityCriteria":176,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":177,"enrollmentInfo":178,"targetDuration":4,"studyType":22,"phases":180,"briefSummary":181,"conditions":182,"keywords":4,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":185,"lastUpdatePostDateStruct":186,"startDateStruct":188,"completionDateStruct":190,"leadSponsor":192,"locationsCount":42},"100637810","electrolyte-beverage-combined-with-polyethylene-glycol-for-colonoscopy-bowel-preparation-100637810","NCT07608120","Electrolyte Beverage Combined With Polyethylene Glycol for Colonoscopy Bowel Preparation","Randomized Controlled Trial of Different Ratios of Electrolyte Beverage and Water Combined With Polyethylene Glycol on Bowel Preparation Quality and Ingestion Rhythm Before Colonoscopy","Inclusion Criteria:\n\n* Adults aged 18-75 years scheduled to undergo elective colonoscopy\n* Meet the standard clinical indications for colonoscopy;\n* Able to understand and comply with the bowel preparation procedure and complete oral polyethylene glycol (PEG) intake as required;\n* Able to comply with study-related data collection and follow-up;\n* Provide written informed consent voluntarily.\n\nExclusion Criteria:\n\n* Previously diagnosed colorectal cancer, intestinal obstruction, or suspected intestinal obstruction;\n* Active gastrointestinal bleeding or a definite history of gastrointestinal bleeding within the past 4 weeks (including melena, hematochezia, or hematemesis);\n* Severe renal insufficiency, decompensated heart failure, significant electrolyte imbalance, or other conditions unsuitable for PEG bowel preparation;\n* Known allergy to polyethylene glycol or components of the electrolyte beverage used in the study;\n* Pregnant or breastfeeding women;\n* Any other condition considered by the investigators to make the participant unsuitable for the study.","75 Years",{"count":179,"type":21},405,[24],"This randomized controlled trial aims to evaluate the effects of different ratios of electrolyte beverage and water combined with polyethylene glycol (PEG) on bowel preparation quality before colonoscopy. Participants undergoing elective colonoscopy will be randomly assigned to one of three bowel preparation regimens: PEG prepared with water only, PEG prepared with a low ratio of electrolyte beverage and water, or PEG prepared with a medium ratio of electrolyte beverage and water. The primary outcome is adequate bowel preparation assessed by the Boston Bowel Preparation Scale (BBPS). Secondary outcomes include bowel preparation completion rate, tolerability, adverse events, repeat colonoscopy rate, adenoma detection rate, and ingestion rhythm characteristics during bowel preparation. This study also aims to explore whether electrolyte beverage-assisted bowel preparation may improve bowel cleansing quality by influencing participants' ingestion rhythm and adherence during PEG intake.",[29,183,184],"Bowel Preparation Solutions","Colorectal Cancer Screening","2026-05-24",{"date":187,"type":34},"2026-05-27",{"date":189,"type":34},"2026-05-18",{"date":191,"type":21},"2027-05-31",{"name":193,"class":41},"Nanfang Hospital, Southern Medical University",{"id":195,"slug":196,"hasResults":12,"nctId":197,"briefTitle":198,"officialTitle":199,"acronym":200,"eligibilityCriteria":201,"healthyVolunteers":16,"sex":17,"minAge":202,"maxAge":4,"enrollmentInfo":203,"targetDuration":4,"studyType":22,"phases":205,"briefSummary":206,"conditions":207,"keywords":4,"overallStatus":57,"whyStopped":4,"lastUpdateSubmitDate":189,"lastUpdatePostDateStruct":209,"startDateStruct":211,"completionDateStruct":213,"leadSponsor":215,"locationsCount":42},"100639580","triton-15-robotic-system-for-diagnostic-colonoscopy-100639580","NCT07606963","Triton 1.5 Robotic System for Diagnostic Colonoscopy","Initial Clinical Experience With the Triton 1.5 Robotic System for Diagnostic Colonoscopy","CARE II","Inclusion Criteria:\n\n1. Age ≥ 22 years\n2. Adults indicated for elective screening, surveillance or diagnostic colonoscopy\n3. Subject is willing and able to provide written informed consent prior to receiving any non-standard of care protocol specific procedures\n4. Subject is willing and able to comply with all protocol required preparation and follow- up visits\n\nExclusion Criteria:\n\n1. Any medical or physical condition\u002Flimitation that would contraindicate a conventional colonoscopy. This assessment will be made by the investigator.\n2. Any active or magnetic implantable medical devices (e.g., pacemakers, defibrillators)\n3. Previous failed colonoscopy (except for inadequate bowel preparation)\n4. BMI \\> 45 kg\u002Fm2\n5. Pregnant participants, women of reproductive potential (pre-menopausal and\u002For no history of hysterectomy), confirmed by a positive pregnancy test (serum).\n6. Surgically altered colonic anatomy\n7. History of colorectal cancer, inflammatory bowel disease, polyposis syndrome, hereditary nonpolyposis colorectal cancer (Lynch) syndrome, sclerosing encapsulating peritonitis, active diverticulitis in last 6 months or toxic megacolon\n8. Lower gastrointestinal bleeding within 28 days prior to the colonoscopy day\n9. Known bleeding tendency such as hemophilia or coagulation factor deficiencies\n10. Subject receiving antiplatelet or anticoagulation therapy apart from low-dose aspirin\n11. Known colonic stricture\n12. Known risk factors for abdominal adhesions such as history of complex abdominal or pelvis surgical procedures, based on investigator assessment\n13. Known abdominal wall hernias\n14. History of radiotherapy to the abdomen or pelvis\n15. History of mesenteric ischemia\n16. Known coronary ischemia or cardiovascular stroke within 3 months prior to the colonoscopy procedure\n17. Contraindication to the proposed sedation \u002F anesthesia\n18. Received any investigational medicine or treatment within 28 days prior to the colonoscopy procedure\n19. Received or planning to receive any other endoscopic procedure within 4 weeks prior and 2 weeks after the colonoscopy procedure\n20. Participation in any concurrent clinical trial that may impact the results of this study\n\nIntra-Operative Criteria:\n\n1. Inadequate bowel preparation, defined as a Boston Bowel Preparation Scale (BBPS) (Appendix A) score \\\u003C 2 in any segment.\n2. Any intraoperative finding or condition that, in the Investigator's judgment, would make study participation unsafe or not in the subject's best interest (e.g., significant stricture, tight sigmoid colon precluding safe overtube passage).","22 Years",{"count":204,"type":21},40,[24],"This study is a prospective, single-arm, non-randomized, single-site study, focused on evaluating the safety and efficacy of the Triton 1.5 System in diagnostic and basic therapeutic colonoscopy.",[29,184,129,208],"Gastrointestinal Endoscopy",{"date":210,"type":34},"2026-05-26",{"date":212,"type":21},"2026-08-01",{"date":214,"type":21},"2026-10-15",{"name":216,"class":217},"Neptune Medical","INDUSTRY",{"id":219,"slug":220,"hasResults":12,"nctId":221,"briefTitle":222,"officialTitle":223,"acronym":4,"eligibilityCriteria":224,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":177,"enrollmentInfo":225,"targetDuration":4,"studyType":51,"phases":4,"briefSummary":227,"conditions":228,"keywords":231,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":165,"lastUpdatePostDateStruct":234,"startDateStruct":236,"completionDateStruct":237,"leadSponsor":239,"locationsCount":42},"100618752","analysis-of-factors-influencing-the-quality-of-bowel-preparation-before-colonoscopy-in-ibd-patients-100618752","NCT07335705","Analysis of Factors Influencing the Quality of Bowel Preparation Before Colonoscopy in IBD Patients","Analysis of Factors Influencing the Quality of Bowel Preparation Before Colonoscopy in IBD Patients: A National Multicenter Prospective Study","Inclusion Criteria:\n\n* Patients aged 18 years or older, of any gender, scheduled for colonoscopy;\n* Patients diagnosed with Inflammatory Bowel Disease (IBD) according to the 2023 edition of the Guidelines for the Diagnosis and Treatment of Inflammatory Bowel Disease;\n* Voluntary participation in this study and provision of signed informed consent.\n\nExclusion Criteria:\n\n* History of acute myocardial infarction (within the past 6 months), severe cardiac, hepatic, or renal insufficiency, or psychiatric disorders;\n* Current use of anticoagulants (e.g., aspirin, warfarin) or presence of coagulation disorders;\n* Pregnant or lactating women;\n* Acute intestinal infection within the past 2 weeks;\n* History of colorectal tumors, familial adenomatous polyposis, or Peutz-Jeghers syndrome;\n* History of intestinal obstruction, perforation, stenosis, or any other condition preventing completion of the examination;\n* Severe hearing impairment, cognitive dysfunction, or inability to cooperate with the survey;\n* Individuals already enrolled in this study who schedule a repeat colonoscopy;\n* Currently participating in another clinical observational trial or having participated in any other clinical trial within the past 60 days;\n* Refusal to sign the written informed consent form.",{"count":226,"type":21},1000,"The primary objectives of this project are twofold. On the one hand, it aims to investigate the current status of bowel preparation protocols and their quality in IBD patients undergoing colonoscopy, particularly focusing on the implementation of these protocols across hospitals following the release of the 2023 bowel preparation guidelines. This will further standardize and optimize bowel preparation practices in China. On the other hand, the project seeks to identify and examine various risk factors contributing to poor bowel preparation quality in IBD patients, analyze their correlation with bowel preparation scores, and develop a risk prediction model for failed bowel preparation. This will provide a theoretical foundation for formulating personalized bowel preparation regimens tailored to individual patient conditions in the future.",[229,29,230],"IBD (Inflammatory Bowel Disease)","Colonoscopy: Bowel Preparation",[232,29,233],"IBD","Bowel preparation",{"date":235,"type":34},"2026-05-14",{"date":36,"type":34},{"date":238,"type":21},"2026-10-01",{"name":240,"class":41},"Changhai Hospital",{"id":242,"slug":243,"hasResults":12,"nctId":244,"briefTitle":245,"officialTitle":246,"acronym":4,"eligibilityCriteria":247,"healthyVolunteers":12,"sex":17,"minAge":18,"maxAge":177,"enrollmentInfo":248,"targetDuration":4,"studyType":22,"phases":249,"briefSummary":250,"conditions":251,"keywords":252,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":165,"lastUpdatePostDateStruct":253,"startDateStruct":254,"completionDateStruct":256,"leadSponsor":258,"locationsCount":42},"100620148","pre-packaged-low-residue-diet-for-bowel-preparation-in-patients-with-inflammatory-bowel-disease-100620148","NCT07353853","Pre-packaged Low-residue Diet for Bowel Preparation in Patients With Inflammatory Bowel Disease","Pre-packaged Low-residue Diet for Bowel Preparation in Patients With Inflammatory Bowel Disease: A National Multicenter Randomized Controlled Non-inferiority Clinical Trial","Inclusion Criteria:\n\n* Age: Adult patients between 18 and 75 years old;\n* Diagnosis of IBD according to the 2023 Guidelines for the Diagnosis and Treatment of Inflammatory Bowel Disease;\n* Voluntary participation in this clinical trial and provision of signed informed consent.\n\nExclusion Criteria:\n\n* Patients with acute IBD, severe conditions, combined with major bleeding, suspected toxic megacolon, CD with severe intestinal stricture, gastrointestinal obstruction, or other conditions deemed unsuitable for colonoscopy by the physician;\n* Patients with severe cardiac, pulmonary, hepatic, or renal dysfunction;\n* History of previous colorectal surgical resection or use of medications that may affect intestinal motility within one week (e.g., antidepressants, sedatives, calcium channel blockers);\n* History of stroke, spinal cord injury, or psychiatric disorders that impair compliance with bowel preparation and colonoscopy;\n* Allergy to any component of the administered drugs or meal replacements;\n* Pregnant or lactating women, and other individuals considered unsuitable for bowel preparation and colonoscopy by the physician.",{"count":226,"type":21},[24],"The primary objectives of this project are twofold: firstly, to evaluate the role of Maifu Changqing® Complete Nutrition Formula Powder in bowel preparation for colonoscopy in patients with IBD; and secondly, to enhance the nutritional support and comfort of bowel preparation for IBD patients.",[229,29,230],[232,29,233],{"date":235,"type":34},{"date":255,"type":34},"2026-01-01",{"date":257,"type":21},"2026-06-30",{"name":240,"class":41},{"id":260,"slug":261,"hasResults":12,"nctId":262,"briefTitle":263,"officialTitle":263,"acronym":4,"eligibilityCriteria":264,"healthyVolunteers":12,"sex":17,"minAge":18,"maxAge":265,"enrollmentInfo":266,"targetDuration":4,"studyType":22,"phases":268,"briefSummary":269,"conditions":270,"keywords":272,"overallStatus":57,"whyStopped":4,"lastUpdateSubmitDate":276,"lastUpdatePostDateStruct":277,"startDateStruct":279,"completionDateStruct":281,"leadSponsor":283,"locationsCount":42},"100592130","visualization-of-the-colon-through-use-of-the-magnetic-flexible-endoscope-mfe-in-participants-with-inflammatory-bowel-disease-ibd-100592130","NCT06989424","Visualization of the Colon Through Use of the Magnetic Flexible Endoscope (MFE) in Participants With Inflammatory Bowel Disease (IBD)","Inclusion Criteria:\n\n* Male or female, 18 to 70 years of age\n* Able to provide written informed consent\n* American Society of Anesthesiologists (ASA) class \\\u003C 3\n* No significant medical problems\n* Abdominal circumference \\\u003C 96 cm\n* Stable, non-flaring inflammatory bowel disease (e.g. Ulcerative Colitis and Crohn's Disease)\n\nExclusion Criteria:\n\n* Patients who do not meet inclusion criteria\n* Patients who are unable or unwilling to provide informed consent\n* Magnetic implants and wearable devices (such as insulin pumps)\n* Females who are pregnant. As part of routine pre-operative care, all females of childbearing potential will undergo either urine or blood pregnancy testing.\n* Cancer positive subjects or any patients currently undergoing any treatment or therapy to treat, cure, or mitigate cancer.\n* Symptoms consistent with coronavirus (COVID-19) --- pyrexia, new persistent cough, or anosmia --- or a positive coronavirus (COVID-19) polymerase chain reaction (PCR) swab result\n* Previous incomplete or failed colonoscopy\n* Colonic resection\n* Severe diverticulosis\n* Known or suspected colonic stricture\n* Previous radiation therapy to the abdomen or pelvis\n* Actively flaring inflammatory bowel condition (e.g. active flare of IBD or diverticulitis)\n* Known or suspected bowel obstruction\n* Presence of ascites\n* Participants taking anticoagulant medications or antiplatelet therapy (excluding aspirin) within the last 3 days\n* Known coagulation disorder (INR ≥ 1.5 or platelets \\\u003C 150 x 109)\n* Known to have phenylketonuria or Glucose-6-Phosphate-Dehydrogenase (G6PD) deficiency\n* Abdominal surgery within the last 6 months\n* Drug or alcohol abuse","70 Years",{"count":267,"type":21},6,[24],"In this study, the investigators will test the ability of the Magnetic Flexible Endoscope (MFE) to travel through the colon of people with Inflammatory Bowel Disease (IBD). The MFE is a device made of ultra-flexible tubing that contains a camera, light, and magnet at the tip. The tip of the tube is about the size of a penny. The magnet inside the tip allows the MFE to be moved through the colon by a second magnet attached to a robotic arm that is outside the body. The purpose of this study is to see how the MFE travels through the colon of IBD patients and if it is tolerable.",[271,29],"Inflammatory Bowel Disease (IBD)",[29,273,274,275,100,271],"Colon","Robotic","Magnetic","2026-04-19",{"date":278,"type":34},"2026-04-21",{"date":280,"type":21},"2026-07",{"date":282,"type":21},"2027-01",{"name":284,"class":41},"Vanderbilt University Medical Center",{"id":286,"slug":287,"hasResults":12,"nctId":288,"briefTitle":289,"officialTitle":290,"acronym":4,"eligibilityCriteria":291,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":177,"enrollmentInfo":292,"targetDuration":4,"studyType":22,"phases":294,"briefSummary":295,"conditions":296,"keywords":4,"overallStatus":57,"whyStopped":4,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":297,"startDateStruct":299,"completionDateStruct":301,"leadSponsor":303,"locationsCount":4},"100631537","effect-of-a-novel-colonoscopic-lavage-solution-on-colonoscopy-quality-100631537","NCT07501975","Effect of a Novel Colonoscopic Lavage Solution on Colonoscopy Quality","Effect of a Novel Colonoscopic Lavage Solution on Colonoscopy Quality: A Randomized Controlled Trial Evaluating Efficacy and Safety","Inclusion Criteria:\n\n1. Age between 18 and 75 years, regardless of gender;\n2. Scheduled to undergo colonoscopy (for screening, diagnostic, or follow-up purposes);\n3. Adequate bowel preparation quality (Boston Bowel Preparation Scale score ≥ 6);\n4. Voluntarily signed informed consent and able to cooperate with completing study-related assessments.\n\nExclusion Criteria:\n\n1. Allergy to menthol, cyclodextrin, or related substances;\n2. History of severe intestinal diseases (such as ulcerative colitis, Crohn's disease, intestinal perforation, intestinal obstruction, intestinal tumors, etc.);\n3. Presence of severe dysfunction of vital organs such as the heart, liver, kidneys, or lungs, or coagulation disorders;\n4. Pregnant or lactating women;\n5. Use of anticholinergic drugs, calcium channel blockers, or other spasmolytic agents within one week prior to the examination;\n6. Psychiatric disorders or cognitive impairment that prevent cooperation with the study;\n7. History of contraindications to colonoscopy or serious adverse reactions during previous procedures.",{"count":293,"type":21},498,[24],"In recent years, with the continuous advancement of digestive endoscopy techniques, how to improve the adenoma detection rate (ADR) by optimizing endoscopic procedural details has become a research hotspot. Colonic spasm can lead to narrowing of the intestinal lumen, deepening of mucosal folds, and limited field of view, thereby affecting lesion exposure and reducing examination quality. Although traditional intravenous antispasmodic drugs (such as scopolamine) can alleviate intestinal spasms, they may cause side effects such as increased heart rate, blood pressure fluctuations, and other systemic adverse reactions. In contrast, menthol is a natural monoterpene compound derived from peppermint oil. It can inhibit L-type calcium channels on the cell membrane of smooth muscle through local application, thereby reducing intracellular calcium concentration and inducing smooth muscle relaxation. This helps to relieve intestinal spasms and patient discomfort during colonoscopy. On the other hand, simethicone, a commonly used defoaming agent, can reduce surface tension, eliminate foam, and improve mucosal visualization. Theoretically, combining antispasmodic menthol with defoaming simethicone may further optimize the visual field during colonoscopy and increase the ADR through a synergistic \"antispasmodic + defoaming\" mechanism. Therefore, this study plans to conduct a prospective randomized controlled trial to evaluate the antispasmodic effect, safety, and impact on the ADR of a novel irrigation solution (0.1% menthol combined with simethicone suspension) in colonoscopy, providing evidence-based medical support for optimizing endoscopic procedures.",[29],{"date":298,"type":34},"2026-03-30",{"date":300,"type":21},"2026-04-01",{"date":302,"type":21},"2026-12-31",{"name":304,"class":41},"The First Affiliated Hospital of Zhengzhou University",{"id":306,"slug":307,"hasResults":12,"nctId":308,"briefTitle":309,"officialTitle":310,"acronym":4,"eligibilityCriteria":291,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":177,"enrollmentInfo":311,"targetDuration":4,"studyType":22,"phases":313,"briefSummary":314,"conditions":315,"keywords":4,"overallStatus":57,"whyStopped":4,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":316,"startDateStruct":317,"completionDateStruct":318,"leadSponsor":319,"locationsCount":4},"100631536","effect-of-intraluminal-administration-of-menthol-solution-during-colonoscopy-on-colonic-spasm-and-adenoma-detection-rate-100631536","NCT07501962","Effect of Intraluminal Administration of Menthol Solution During Colonoscopy on Colonic Spasm and Adenoma Detection Rate","Effect of Intraluminal Administration of Menthol Solution During Colonoscopy on Colonic Spasm and Adenoma Detection Rate: An Efficacy and Safety Study",{"count":312,"type":21},440,[24],"In recent years, with increasing research into antispasmodic agents, topical antispasmodics have attracted considerable attention due to their direct action on the gastrointestinal mucosa and relatively low incidence of adverse reactions. Menthol, a natural terpenoid compound found in peppermint oil, has been confirmed by numerous studies to possess spasmolytic properties. Existing evidence indicates that menthol relaxes intestinal smooth muscle and alleviates spasm symptoms by antagonizing L-type calcium channels on the smooth muscle cell membrane, thereby reducing calcium influx. Furthermore, it exhibits local analgesic effects and can attenuate visceral hypersensitivity. Some studies suggest that oral or topical administration of peppermint oil preparations may improve intestinal spasm during colonoscopy, highlighting its potential utility in digestive endoscopy procedures. Nevertheless, current research on the spasmolytic efficacy and safety of menthol solution when administered via endoscopic irrigation during colonoscopy remains limited, and high-quality clinical trials are urgently needed for validation. This study aims to investigate the effectiveness and safety of menthol solution in relieving intestinal spasm, thereby providing scientific evidence for optimizing colonoscopy procedures.",[29],{"date":298,"type":34},{"date":300,"type":21},{"date":302,"type":21},{"name":304,"class":41},{"id":321,"slug":322,"hasResults":12,"nctId":323,"briefTitle":324,"officialTitle":325,"acronym":326,"eligibilityCriteria":327,"healthyVolunteers":12,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":328,"targetDuration":4,"studyType":22,"phases":330,"briefSummary":331,"conditions":332,"keywords":334,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":338,"lastUpdatePostDateStruct":339,"startDateStruct":341,"completionDateStruct":342,"leadSponsor":344,"locationsCount":346},"100615935","efficacy-of-cad-in-screening-colonoscopy-to-reduce-the-risk-of-advanced-adenoma-at-3-years-100615935","NCT07299071","Efficacy of CAD in Screening Colonoscopy to Reduce the Risk of Advanced Adenoma at 3 Years.","Randomized Controlled Trial Evaluating the Efficacy of CAD in Screening Colonoscopy to Reduce the Risk of Advanced Adenoma at 3 Years.","IA-COLO 2","Inclusion Criteria:\n\n* Patients over 18 years of age with indication for colonoscopy as part of a screening program, after a positive immunological (FIT) test, and\u002For for personal or family history of colorectal cancer and\u002For personal history of colonic adenomas,\n* Written informed consent signed\n* Patients covered by a health-care insurance.\n\nExclusion Criteria:\n\n* Failed complete colonoscopy, defined by the absence of cecal intubation and\u002For the absence of terminal ileum cauterization\n* Inadequate bowel preparation (Boston bowel preparation score \\\u003C 6, and\u002For least at one part of colon with score ≤ 1)\n* An infiltrative tumor was diagnosed during colonoscope insertion time, not accessible to endoscopic resection and likely to require surgical management (a procedure where part of the colon may need to be removed).\n* Patient under guardianship or protection\n* Pregnant women\n* Not fluent in French or illiterate\n* Personal history of inflammatory bowel disease\n* Personal history of genetic predisposition of CRC\n* Personal history of colonic surgery",{"count":329,"type":21},592,[24],"The occurrence of interval cancers after colonoscopy raises the possibility of missed lesions. High- performance computer aided diagnosis (CAD) systems have been specially designed for the detection of colorectal lesions (CAD for detection is named CADe). The use of CADe improves adenoma detection in screening colonoscopy. The potential of CADe system in reducing the rate of progression to advanced polyps or interval cancer between two colonoscopies remains still uncertain.",[29,129,333],"Intestinal Polyps",[335,336,337],"colonoscopy","colorectal neoplasms","computer aided diagnosis","2026-03-13",{"date":340,"type":34},"2026-03-16",{"date":338,"type":34},{"date":343,"type":21},"2031-03",{"name":345,"class":41},"University Hospital, Bordeaux",13,{"id":348,"slug":349,"hasResults":12,"nctId":350,"briefTitle":351,"officialTitle":352,"acronym":353,"eligibilityCriteria":354,"healthyVolunteers":12,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":355,"targetDuration":4,"studyType":22,"phases":357,"briefSummary":358,"conditions":359,"keywords":362,"overallStatus":57,"whyStopped":4,"lastUpdateSubmitDate":367,"lastUpdatePostDateStruct":368,"startDateStruct":370,"completionDateStruct":372,"leadSponsor":374,"locationsCount":42},"100613229","enhanced-ward-rounds-for-bowel-preparation-quality-in-hospitalized-patients-undergoing-colonoscopy-100613229","NCT07263867","Enhanced Ward Rounds for Bowel Preparation Quality in Hospitalized Patients Undergoing Colonoscopy","Effect of Increased Frequency of Resident Ward Rounds on Bowel Preparation Quality in Hospitalized Patients Undergoing Therapeutic Colonoscopy: A Cluster-Randomized Crossover Trial","ENHANCE-BP","Inclusion Criteria:\n\n1. Age ≥18 years\n2. Hospitalized patients (inpatients)\n3. Scheduled for therapeutic colonoscopy (polypectomy, endoscopic mucosal resection \\[EMR\\], endoscopic submucosal dissection \\[ESD\\], or biopsy for diagnosis)\n4. Time from admission to scheduled colonoscopy ≥48 hours (allowing adequate preparation time)\n5. Patient or legal representative able to provide written informed consent\n6. Able to understand and follow bowel preparation instructions (with assistance from caregivers if needed)\n\nExclusion Criteria:\n\n1. Emergency gastrointestinal conditions: bowel obstruction, acute lower gastrointestinal bleeding requiring urgent intervention, suspected or confirmed perforation\n2. Emergency or same-day colonoscopy (scheduled \\\u003C24 hours after admission)\n3. History of total colectomy or current colostomy\u002Fileostomy\n4. Severe cognitive impairment (Mini-Cog score 0-1 or MMSE \\\u003C18) without available caregiver\n5. Severe cardiopulmonary disease: New York Heart Association (NYHA) Class IV heart failure, chronic kidney disease (CKD) stage 4-5 (eGFR \\\u003C30 ml\u002Fmin\u002F1.73m²) unable to tolerate PEG-based preparation\n6. Known or suspected pregnancy, currently breastfeeding\n7. Previous severe allergic reaction to PEG or bowel preparation agents\n8. Current participation in another interventional clinical trial\n9. Unable to provide informed consent and no legal representative available\n10. Patient or legal representative declines participation",{"count":356,"type":21},300,[24],"Adequate bowel preparation is critical for successful colonoscopy, yet inadequate preparation remains a significant clinical challenge, occurring in 20-30% of procedures. In hospitalized patients undergoing therapeutic colonoscopy, suboptimal preparation leads to increased costs, prolonged hospital stay, and potential procedure cancellation or rescheduling. Current standard care involves resident ward rounds twice daily.\n\nThis cluster-randomized crossover trial aims to evaluate whether increasing the frequency of structured resident ward rounds from 2 to 4 times per day can improve bowel preparation quality in hospitalized patients scheduled for therapeutic colonoscopy. The enhanced ward round intervention includes standardized checklist review, medication verification, dietary compliance confirmation, adverse event screening, and timely intervention when needed.\n\nThree hospital wards will be randomly assigned to different sequences of intervention and control periods using a crossover design with washout periods. The primary outcome is adequate bowel preparation quality assessed by Boston Bowel Preparation Scale (BBPS ≥6 with each segment ≥2), evaluated by blinded endoscopists. Secondary outcomes include procedure quality metrics (cecal intubation rate, examination duration), safety endpoints (electrolyte disturbances, aspiration events), health economics measures (length of stay, total costs), and healthcare worker burden (nursing workload, night-time call frequency).\n\nSubgroup analyses will examine intervention effects across age groups, cognitive function levels, prior colonoscopy experience, and comorbidity burden to identify populations most likely to benefit from enhanced monitoring.\n\nThis pragmatic trial addresses a clinically relevant question using a real-world implementation strategy designed to minimize workflow disruption. Results will inform evidence-based policies regarding optimal ward round frequency for colonoscopy preparation in hospital settings.",[29,360,361],"Bowel Preparation","Quality of Healthcare",[233,363,364,365,366],"Ward rounds","Colonoscopy quality","Cluster randomized trial","Boston Bowel Preparation Scale","2026-03-04",{"date":369,"type":34},"2026-03-06",{"date":371,"type":21},"2026-03-28",{"date":373,"type":21},"2026-12-30",{"name":375,"class":41},"LanZhou University",{"id":377,"slug":4,"hasResults":12,"nctId":378,"briefTitle":379,"officialTitle":380,"acronym":4,"eligibilityCriteria":381,"healthyVolunteers":12,"sex":17,"minAge":122,"maxAge":177,"enrollmentInfo":382,"targetDuration":4,"studyType":22,"phases":384,"briefSummary":385,"conditions":386,"keywords":4,"overallStatus":57,"whyStopped":4,"lastUpdateSubmitDate":388,"lastUpdatePostDateStruct":389,"startDateStruct":391,"completionDateStruct":393,"leadSponsor":395,"locationsCount":4},"100621039","NCT07365436","Imaging the Colon Using a Colonoscope Compatible Imaging Probe","Study for Imaging the Lower Gastrointestinal Tract Using a Colonoscopy-Compatible OCT Probe","Inclusion Criteria:\n\n* 45 years of age or older\n* Capable of giving informed consent\n* Capable of following bowel prep instructions\n\nExclusion Criteria:\n\n* 75 years of age or older\n* Any contraindication to bowel prep or colonoscopy\n* Current diagnosis of any bleeding disorders\n* Currently using drugs that interfere with coagulation (excluding low-dose aspirin)\n* Pregnancy",{"count":383,"type":21},250,[24],"The goal of this study is to use a colonoscope compatible device capable of taking images of the lower gastrointestinal tract. The main question it aims to answer is:\n\nIs the colonoscope compatible optical coherence tomography probe (CC-OCT probe) an effective device to use to take images of the gut?\n\nDuring the participant's standard of care colonoscopy, the CC-OCT probe will be inserted into the colonoscope. The CC-OCT probe will then collect images of the participant's gastrointestinal tract in real time.",[387,29],"Colon Polyps","2026-01-22",{"date":390,"type":34},"2026-01-26",{"date":392,"type":21},"2026-03",{"date":394,"type":21},"2029-12",{"name":396,"class":41},"Massachusetts General Hospital",{"id":398,"slug":399,"hasResults":12,"nctId":400,"briefTitle":401,"officialTitle":402,"acronym":4,"eligibilityCriteria":403,"healthyVolunteers":12,"sex":17,"minAge":404,"maxAge":177,"enrollmentInfo":405,"targetDuration":407,"studyType":51,"phases":4,"briefSummary":408,"conditions":409,"keywords":412,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":418,"lastUpdatePostDateStruct":419,"startDateStruct":421,"completionDateStruct":423,"leadSponsor":425,"locationsCount":427},"100620131","what-influence-re-participation-in-the-danish-colorectal-screening-program-100620131","NCT07353632","What Influence Re-participation in the Danish Colorectal Screening Program.","Re-participation for Screening-colonoscopy - Experience of colonoscpy_1","Inclusion Criteria:\n\n* Adults undergoing screening-derived colonoscopy as part of the Danish colorectal cancer screening program\n* Written informed consent\n\nExclusion Criteria:\n\n* Inability to understand or communicate in Danish\n* Lack of decision-making capacity, including cognitive impairment due to dementia or brain injury\n* Declines or withdraws informed consent","50 Years",{"count":406,"type":21},8000,"3 Years","This prospective observational study investigates how participants experience screening colonoscopy within the Danish colorectal cancer screening program and how these experiences relate to clinical findings, procedural factors, and future participation in screening.\n\nThe study aims to evaluate patient-reported experiences such as pain, discomfort, preparation burden, emotional responses, and perceptions of healthcare staff, as well as staff-assessed pain during the procedure. These experiences will be examined in relation to colonoscopy findings, including polyp detection, histology, risk stratification, and colorectal cancer detection. In addition, procedure-specific variables such as insertion time, bowel preparation quality, completeness of colonoscopy, medication use, and adenoma detection rate will be analyzed in relation to patient experience.\n\nA key focus is whether the experience of screening colonoscopy influences subsequent participation in the colorectal cancer screening program, particularly among individuals classified as low risk and re-invited for screening after two years. Registry-based follow-up will be used to assess re-participation.\n\nData are collected prospectively from two sources: (1) real-time procedure data entered by healthcare staff during colonoscopy and (2) patient-reported outcomes collected via a questionnaire completed shortly after the procedure. Additional outcome data are obtained from electronic medical records and national health and screening registries.\n\nThe study has no single predefined hypothesis. Instead, it serves as a data-generating platform designed to address both predefined and future research questions related to screening colonoscopy experiences, quality indicators, and screening adherence.",[29,410,411],"Screening Colonscopy","Pain",[413,414,415,416,417],"Screening colonoscopy experience","Colorectal cancer screening","Patient-reported outcomes","Pain perception during colonoscopy","Screening re-participation","2026-01-19",{"date":420,"type":34},"2026-01-20",{"date":422,"type":34},"2024-09-23",{"date":424,"type":21},"2027-06-30",{"name":426,"class":41},"Esbjerg Hospital - University Hospital of Southern Denmark",8,{"id":429,"slug":430,"hasResults":12,"nctId":431,"briefTitle":432,"officialTitle":432,"acronym":4,"eligibilityCriteria":433,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":434,"targetDuration":4,"studyType":22,"phases":436,"briefSummary":437,"conditions":438,"keywords":439,"overallStatus":57,"whyStopped":4,"lastUpdateSubmitDate":441,"lastUpdatePostDateStruct":442,"startDateStruct":444,"completionDateStruct":445,"leadSponsor":446,"locationsCount":4},"100618905","exploring-the-clinical-value-of-an-ai-assisted-patient-self-assessment-app-for-bowel-preparation-a-multicenter-study-100618905","NCT07337694","Exploring the Clinical Value of an AI-Assisted Patient Self-Assessment App for Bowel Preparation: A Multicenter Study","Inclusion Criteria:\n\n1. Age ≥ 18 years\n2. Undergoing colonoscopy at a participating site\n3. Able to defecate in a toilet (or in a setting where stool characteristics can be observed) after taking the bowel-prep solution\n4. Proficient in using a smartphone\n5. Willing to participate voluntarily\n\nExclusion Criteria:\n\n* American Society of Anesthesiologists (ASA) class III or IV;\n\n  * Gastric-outlet or intestinal obstruction; ③ Active gastrointestinal bleeding; ④ Enterostomy (colostomy\u002Fileostomy); ⑤ Status post total colectomy.",{"count":435,"type":21},524,[24],"The quality of bowel preparation hinges on how well patients follow the prep-drug regimen, so intensive education is essential. Phone calls, texts, short videos, and mini-programs have all been shown to boost compliance and improve prep quality. Still, we also need a way to spot-early-those patients who are likely to prep poorly so we can step in with a rescue plan.\n\nIn our pilot work the investigators built an AI-assisted mini-program that lets patients photograph their effluent and get an instant quality read-out. The single-center RCT showed excellent performance. Because these findings came from one center, the investigators are now launching a multicenter study to test the tool more broadly. Patients will use the AI mini-program at home; if the algorithm predicts inadequate prep it will prompt them to come in early or alert staff so the investigators can initiate a rescue protocol and, ultimately, improve bowel-cleansing quality.",[28,29],[233,29,440],"Artificial intelligence","2026-01-16",{"date":443,"type":34},"2026-01-21",{"date":255,"type":21},{"date":143,"type":21},{"name":447,"class":41},"Sixth Affiliated Hospital, Sun Yat-sen University",{"id":449,"slug":450,"hasResults":12,"nctId":451,"briefTitle":452,"officialTitle":453,"acronym":454,"eligibilityCriteria":455,"healthyVolunteers":12,"sex":17,"minAge":18,"maxAge":456,"enrollmentInfo":457,"targetDuration":4,"studyType":22,"phases":459,"briefSummary":460,"conditions":461,"keywords":463,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":467,"lastUpdatePostDateStruct":468,"startDateStruct":469,"completionDateStruct":471,"leadSponsor":473,"locationsCount":475},"100620296","video-tutorial-and-oral-explanation-vs-oral-explanation-alone-in-colonoscopy-preparation-100620296","NCT07355777","Video Tutorial and Oral Explanation Vs Oral Explanation Alone in Colonoscopy Preparation","Prospective Multicenter Randomized Trial Comparing Oral Explanation Alone and With Video Tutorial for Bowel Preparation Quality and Adenoma Detection","PREPACOTUTO","Inclusion Criteria:\n\n* Consecutive patients undergoing their first colonoscopy for gastrointestinal symptoms, family history of CRC or suspected CRC.\n* Ability to use the internet and a link to a video.\n* Life expectancy over three months.\n* Patient ≥ 18 years old, requiring a colonoscopy procedure.\n\nExclusion Criteria:\n\n* Patient with any psychiatric or psychological disorder that does not allow them a properd understanding and follow-up of the study.\n* Patient without internet access.\n* Patient requiring a colonoscopy procedure in emergency","80 Years",{"count":458,"type":21},574,[24],"Colonoscopy which is the standard examination for the exploration of the colon and rectum is performed very frequently.\n\nColon preparation before the examination is an essential step and pescription of the colonic preparation is carried out by the gastroenterologist.\n\nHowever, despite a standardized explanation of the colon preparation, there is heterogeneity in understanding the colonic preparation, which in some cases compromises the quality of the colonoscopy examination. This clinical study aims to investigate whether an explanation of colonic preparation by tutorial films would increase the quality of colon preparation and would reach the recommendations of the Société française d'endoscopie digestive (SFED) in 2019.",[29,462],"Gastro-Intestinal Disorder",[464,335,465,466],"colon preparation","gastro-intestinal disorder","tutorial","2026-01-13",{"date":443,"type":34},{"date":470,"type":34},"2025-04-01",{"date":472,"type":21},"2026-03-31",{"name":474,"class":41},"Centre Hospitalier Saint Joseph Saint Luc de Lyon",5,{"id":477,"slug":478,"hasResults":12,"nctId":479,"briefTitle":480,"officialTitle":481,"acronym":4,"eligibilityCriteria":482,"healthyVolunteers":12,"sex":17,"minAge":18,"maxAge":177,"enrollmentInfo":483,"targetDuration":4,"studyType":51,"phases":4,"briefSummary":484,"conditions":485,"keywords":4,"overallStatus":57,"whyStopped":4,"lastUpdateSubmitDate":486,"lastUpdatePostDateStruct":487,"startDateStruct":489,"completionDateStruct":491,"leadSponsor":493,"locationsCount":4},"100618299","external-multicentre-validation-of-a-machine-learning-model-to-predict-colonic-adenoma-in-indian-adults-100618299","NCT07329816","External, Multicentre Validation of a Machine-Learning Model to Predict Colonic Adenoma in Indian Adults","External, Multicentre Validation of a Machine-Learning Model to Predict Colonic Adenoma in Indian Adults-A Prospective, Observational, Multicentre Study","Inclusion Criteria:\n\n* Adults ≥18 years undergoing diagnostic colonoscopy.\n* Adequate bowel preparation (Boston Bowel Preparation Scale total ≥6 with each segment ≥2).\n* Complete examination (cecal intubation; withdrawal time ≥6 min when no therapy).\n* Availability of all model predictors per CRF.\n\nExclusion Criteria:\n\n* • Known CRC or polyp, prior colectomy, polyposis syndromes, known IBD, or strong hereditary CRC syndromes (e.g., Lynch) if excluded in derivation.\n\n  * Inadequate prep, incomplete colonoscopy, obstructing lesions preventing optical diagnosis beyond obstruction.\n  * Emergency colonoscopies, therapeutic-only procedures without diagnostic intent.",{"count":226,"type":21},"Colorectal adenomas are precursors to colorectal cancer (CRC). Accurate pre-procedure risk stratification could optimize colonoscopy yield and resource allocation in India, where adenoma prevalence varies by age, sex, and lifestyle\u002Fmetabolic factors. ML models can integrate multiple predictors to estimate individualized risk.\n\nExisting risk scores are largely Western; performance and calibration may not be appropriate in Indian populations with different socio-demographic and metabolic profiles. External, prospective, multicentre validation is essential before clinical implementation.",[29],"2026-01-09",{"date":488,"type":34},"2026-01-12",{"date":490,"type":21},"2026-02-01",{"date":492,"type":21},"2027-03-30",{"name":494,"class":41},"Asian Institute of Gastroenterology, India",{"id":496,"slug":497,"hasResults":12,"nctId":498,"briefTitle":499,"officialTitle":499,"acronym":4,"eligibilityCriteria":500,"healthyVolunteers":16,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":501,"targetDuration":503,"studyType":51,"phases":4,"briefSummary":504,"conditions":505,"keywords":508,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":512,"lastUpdatePostDateStruct":513,"startDateStruct":515,"completionDateStruct":517,"leadSponsor":519,"locationsCount":521},"100586845","coloreg-a-register-for-gastrointestinal-endoscopy-reports-and-examination-videos-100586845","NCT06920680","ColoReg: A Register for Gastrointestinal Endoscopy Reports and Examination Videos","Inclusion Criteria:\n\n* Indication for diagnostic or therapeutic colonoscopy\n\nExclusion Criteria:\n\n\\-",{"count":502,"type":21},1834,"1 Year","With the participants help, the investigators aim to track treatment methods, treatment outcomes, and adverse events, as well as document the treatment strategies used during endoscopic colorectal cancer prevention and treatment. This will allow us to verify if the results from targeted clinical studies and current scientific knowledge are also reflected in the real world. Additionally, the investigators want to use the collected videos and findings to support the training of doctors. During each examination, doctors must be able to accurately assess the inside of the body. Teaching materials for this purpose are scarcely available, often outdated (especially images), and usually show obvious cases. The investigators aim to provide doctors with the opportunity to learn outside of real patient examinations and benefit from the experiences of others.\n\nFurthermore, the investigators want to make the findings and video data accessible to the scientific community. Since scientific studies rarely publish raw data for this purpose, there is currently no large and constantly updated database of findings, images, and videos. If a study requires such data, new data must be collected with great organizational and financial effort. As a result, different studies are only partially comparable, and their significance is reduced.\n\nBy publishing the data, a valuable information source for medical professionals in training, continuing education, and advanced training is created. Researchers also benefit from this data: New technologies, such as image analysis software, can be tested and compared on a consistent basis. Therefore, participation in this study makes a valuable contribution to the foundation of good medical care: education, research, and quality assurance.\n\nPrimary Study Goal:\n\nThe study aims to evaluate the effectiveness and safety of different endoscopic resection techniques. Effectiveness is defined as achieving a complete removal of the lesion (R0 resection) or having a clear follow-up in more than 90% of cases. Safety is defined as having less than 3% of cases result in complications like perforation, uncontrollable bleeding, or the need for unplanned follow-up due to issues like interval bleeding or perforation. The target diagnostic accuracy is 95%.\n\nSecondary Study Goals:\n\n1. Ensure that in 90% of cases, the recommended follow-up interval aligns with current national guidelines based on the number, size, and histopathology of polyps.\n2. Achieve successful retrieval of polyps in more than 95% of cases.\n3. Document minor bleedings, defined as continuous bleeding for over 30 seconds that requires clipping.\n\nTertiary Study Goal:\n\nDevelop software that can identify and mask sensitive information (such as names, birth dates, examination dates, and video sections outside the human body) in videos from 1,000 examinations, or flag them for manual review. Similarly, the software should identify and remove sensitive text information in the reports, such as names, birth dates, case numbers, examiners, and phone numbers, or mark the text for manual review.",[506,29,507],"Colorectal Cancer","Polypectomy",[509,335,510,511],"colorectal cancer","standardized documentation","interventional endoscopy","2025-12-15",{"date":514,"type":34},"2025-12-22",{"date":516,"type":34},"2024-10-01",{"date":518,"type":21},"2027-10",{"name":520,"class":41},"Wuerzburg University Hospital",2,{"id":523,"slug":524,"hasResults":12,"nctId":525,"briefTitle":526,"officialTitle":527,"acronym":4,"eligibilityCriteria":528,"healthyVolunteers":16,"sex":17,"minAge":529,"maxAge":530,"enrollmentInfo":531,"targetDuration":4,"studyType":22,"phases":533,"briefSummary":534,"conditions":535,"keywords":536,"overallStatus":57,"whyStopped":4,"lastUpdateSubmitDate":539,"lastUpdatePostDateStruct":540,"startDateStruct":542,"completionDateStruct":543,"leadSponsor":545,"locationsCount":4},"100613013","ai-assisted-integrated-care-to-promote-colonoscopy-uptake-100613013","NCT07261059","AI-assisted Integrated Care to Promote Colonoscopy Uptake","Artificial Intelligence-assisted Integrated Care to Promote Colonoscopy Uptake in China: a Cluster Randomized Controlled Trial","Inclusion Criteria:\n\n* Individuals who test positive on either the Colorectal Cancer Risk Assessment Scale or the fecal immunochemical test (FIT);\n* Aged 40 \\~ 64 years;\n* Proficient in smartphone use and able to engage with the intervention;\n* Provided informed consent .\n\nExclusion Criteria:\n\n* History of colorectal cancer;\n* Contraindications to colonoscopy,(e.g. severe cardiac, cerebral, lung diseases, or renal dysfunction).","40 Years","64 Years",{"count":532,"type":21},400,[24],"Colorectal cancer (CRC) ranks the second most common cancer and the fourth leading cause of cancer-related deaths in China. Early screening of CRC has been proven to reduce the incidence and mortality, with colonoscopy as the gold standard for CRC screening. This trial aims to evaluate the effectiveness of artificial intelligence-assistant integrated care for improving uptake rate of colonoscopy among high-risk individuals aged 40 to 64 in China. It's a two-arm, parallel cluster randomized controlled trial. The main question it aims to answer is whether the AI-assisted integrated care influence participants' screening-related knowledge, health beliefs, behavioral intention, and uptake of colonoscopy.\n\nParticipants will:\n\n1. Be recruited and allocated into one of two groups according to the assigned clusters. Participants in one group will be invited to receive usual specialty care. In addition to usual specialty care, participants in the other group will receive AI-assisted integrated care provided by specialist and general practitioners collaboratively.\n2. Complete a questionnaire survey on their knowledge, health beliefs, behavioral intention on CRC screening.\n3. Have their colonoscopy status checked at the middle and end of trial.",[129,29],[509,335,132,537,538],"integrated care","trial","2025-12-02",{"date":541,"type":34},"2025-12-03",{"date":36,"type":21},{"date":544,"type":21},"2026-12",{"name":145,"class":41},{"id":547,"slug":548,"hasResults":12,"nctId":549,"briefTitle":550,"officialTitle":551,"acronym":4,"eligibilityCriteria":552,"healthyVolunteers":12,"sex":17,"minAge":18,"maxAge":265,"enrollmentInfo":553,"targetDuration":4,"studyType":22,"phases":555,"briefSummary":556,"conditions":557,"keywords":560,"overallStatus":57,"whyStopped":4,"lastUpdateSubmitDate":564,"lastUpdatePostDateStruct":565,"startDateStruct":567,"completionDateStruct":568,"leadSponsor":570,"locationsCount":4},"100613999","real-time-feedback-of-red-out-within-colonoscopy-intubation-100613999","NCT07273890","Real-time Feedback of Red-out Within Colonoscopy Intubation","Prospective, Multicenter, Controlled Study on the Impact of Real-time Feedback on Red-out","Inclusion Criteria:\n\n1. Study Participants (Patients):\n\n   Aged 18 to 70 years, any gender. Individuals scheduled to undergo diagnostic or screening colonoscopy at the investigational site.\n2. Colonoscopists:\n\nExpert-level colonoscopists (having performed a total of \\>1000 colonoscopy procedures).\n\nRight-handed.\n\nExclusion Criteria:\n\n1. Study Participants (Patients):\n\n   Individuals undergoing the following procedures:\n\n   cases with a history of colorectal surgery; cases with a history of chemotherapy, raditherapy; cases with a history of abdominal, and\u002For pelvic surgery; cases with a history of difficult colonoscopies; cases with colorectal tumours and obstructive lesions; cases with colorectal diverticula; cases with ulcerative colitis or Crohn's disease; cases with ischemic bowel disease; cases with colorectal polyposis; cases with melanosis coli; cases undergoing sigmoidoscopy; cases with poor intestional cleanliness (segment Boston bowel preparation scale (BBPS) of \\\u003C 2 points, total BBPS of \\\u003C 6 points); cases undergoing therapy procedures such as biopsy or CSP during the intubation phase; cases with transparent cap assisted colonoscopy; cases with water-assisted colonoscopy; cases with air insufflation level of M or L; cases failed caecal intubation within 15 min; cases with colonoscope stiffness level \\> 0; obese cases or underweight cases; and cases refusing participation.\n\n   Individuals who decline to provide informed consent.\n2. Colonoscopists:\n\nThose who have performed fewer than 300 complete colonoscopies in any calendar year within the past three years.\n\nThose who decline to participate in the study.",{"count":554,"type":21},576,[24],"This study will employ a prospective, multicenter, controlled design. It will be conducted across multiple centers, with participated centers randomly assigned to one of four groups: Group A, Group B, Group C, and Group D.\n\nThe research will primarily focus on the AI-based analysis of colonoscopic images to calculate the following metrics: caecal intubation time, red-out percentage, and the AI-based red-out avoiding score. Based on the study's implementation protocol, a decision will be made regarding whether to provide real-time feedback. Additionally, the presence of any complications will be assessed both during and after the colonoscopy procedure.",[558,29,559],"Artificial Intelligence","Real-time Feedback",[29,561,562,563],"Intubation","Real-time feedback","Red-out","2025-11-27",{"date":566,"type":34},"2025-12-10",{"date":566,"type":21},{"date":569,"type":21},"2028-04-20",{"name":571,"class":41},"The First Affiliated Hospital of Anhui Medical University",{"id":573,"slug":574,"hasResults":12,"nctId":575,"briefTitle":576,"officialTitle":577,"acronym":4,"eligibilityCriteria":578,"healthyVolunteers":12,"sex":17,"minAge":18,"maxAge":456,"enrollmentInfo":579,"targetDuration":4,"studyType":22,"phases":581,"briefSummary":582,"conditions":583,"keywords":4,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":586,"lastUpdatePostDateStruct":587,"startDateStruct":589,"completionDateStruct":591,"leadSponsor":592,"locationsCount":42},"100610552","the-effect-of-video-based-education-on-colonoscopy-preparation-100610552","NCT07229066","The Effect of Video-Based Education on Colonoscopy Preparation","Evaluation of the Effect of Video-Based Education on Bowel Preparation Before Colonoscopy","Inclusion Criteria:\n\n* Voluntary participation in the study.\n* Outpatient follow-up.\n* No prior history of colonoscopy.\n* Participant or a household member (spouse, child, parent, sibling) owns and can use a smartphone application.\n\nExclusion Criteria:\n\n* History of major abdominal surgery.\n* Suspected obstructive lesion in the gastrointestinal tract on cross-sectional imaging.\n* Impaired swallowing reflex.\n* Mental disorder.\n* Communication difficulties (speech, perception, comprehension problems).\n* Congestive heart failure or kidney failure.\n* Pregnancy or breastfeeding.",{"count":580,"type":21},246,[24],"Colonoscopy is a routine procedure for evaluating gastrointestinal symptoms, detecting colorectal cancer, and removing polyps. Its effectiveness depends on patient compliance with bowel preparation instructions. However, inadequate bowel preparation occurs in 20-25% of colonoscopies, often due to non-adherence, medical conditions, or long waiting times. Poor preparation can reduce examination quality, prevent detection of precancerous lesions, and increase healthcare costs. Video-based education has been shown to be more effective than written or verbal instructions in improving bowel preparation. This study aims to evaluate the effect of video-based education on colonoscopy bowel preparation and contribute evidence to optimize patient compliance.",[584,29,585],"Bowel Preparation Quality","Patient Education","2025-11-13",{"date":588,"type":34},"2025-11-14",{"date":590,"type":34},"2024-06-01",{"date":298,"type":21},{"name":593,"class":41},"Eskisehir Osmangazi University",{"id":595,"slug":596,"hasResults":12,"nctId":597,"briefTitle":598,"officialTitle":599,"acronym":600,"eligibilityCriteria":601,"healthyVolunteers":12,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":602,"targetDuration":4,"studyType":22,"phases":603,"briefSummary":604,"conditions":605,"keywords":606,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":613,"lastUpdatePostDateStruct":614,"startDateStruct":616,"completionDateStruct":617,"leadSponsor":619,"locationsCount":42},"100569031","microbiological-and-organizational-impact-of-the-use-of-bacteriologically-controlled-water-in-coloscopy-100569031","NCT06688955","Microbiological and Organizational Impact of the Use of Bacteriologically Controlled Water in COLOscopy","Evaluation of the Microbiological and Organizational Impact of the Use of Bacteriologically Controlled Water in COLOscopy for an Evolution of Our Practices Towards a More Ecoresponsible Endoscopic Activity COLO SOUS L'EAU","COLOSOUS L'EAU","Inclusion Criteria:\n\n* All patients with a colonoscopy indication whose examination is scheduled in room 4, on a Monday and Tuesday shift (8:30 a.m. - 1:30 p.m.)\n* Male or female of legal age at the time the colonoscopy is ordered\n* Patient willing to participate in the study\n* Person affiliated with or benefiting from a social security plan\n\nExclusion Criteria:\n\n* Pregnant woman\n* Patient of legal age under guardianship or protected person\n* Patient requiring indigo-carmine chromoendoscopy\n* Patient requiring an emergency colonoscopy\n* Patient not affiliated to the social security system",{"count":204,"type":21},[24],"A joint opinion of the SFED and the SF2H recommends to orient our colonoscopy practices towards the use of bacteriologically controlled water in reusable bottles for colonic irrigation. To date, no study exists to validate the proposed set-up. Our main objective is therefore to evaluate the microbiological safety of the use of bacteriologically controlled water, in particular the absence of retro contamination of the water in the wash bottle by the faecal flora of the patient undergoing colonoscopy, in order to be able to generalise this practice",[29],[607,608,609,610,611,612],"COLONOSCOPY","WATER","microbiological safety","organization","ecological impacT","plastic waste","2025-09-29",{"date":615,"type":34},"2025-10-03",{"date":613,"type":34},{"date":618,"type":21},"2025-12",{"name":345,"class":41}]